56405-21-1 Usage
Description
DL-4-Hydroxyphenylglycine methyl ester hydrochloride is an organic compound with the molecular formula C9H11NO3·HCl. It is a derivative of amino acids, specifically a hydroxylated phenylalanine with a methyl ester group and a hydrochloride counterion. DL-4-Hydroxyphenylglycine methyl ester hydrochloride is known for its potential applications in various fields due to its unique chemical structure and properties.
Uses
Used in Pharmaceutical Industry:
DL-4-Hydroxyphenylglycine methyl ester hydrochloride is used as an intermediate in the synthesis of various pharmaceutical compounds. Its ability to be modified and incorporated into more complex molecules makes it a valuable building block for drug development.
Used in Preparation of PPAR Activators:
DL-4-Hydroxyphenylglycine methyl ester hydrochloride is used as a starting material or intermediate in the preparation of 2-phenylisoindolin-1-one derivatives or their salts, which act as activators of peroxisome proliferator-activated receptor (PPAR). PPAR activators play a crucial role in regulating cellular differentiation, development, and metabolism, making them important targets for the treatment of various diseases, including diabetes, obesity, and cardiovascular disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 56405-21-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,4,0 and 5 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 56405-21:
(7*5)+(6*6)+(5*4)+(4*0)+(3*5)+(2*2)+(1*1)=111
111 % 10 = 1
So 56405-21-1 is a valid CAS Registry Number.
56405-21-1Relevant articles and documents
Hydroxyphenyl-glycine methyl ester to a method for the synthesis of (by machine translation)
-
Paragraph 0049; 0050; 0051, (2017/02/17)
The invention discloses a synthesis method of p-hydroxyphenylglycine methyl ester. The method comprises the steps of: reacting p-hydroxyphenylglycine or salt thereof which is used as an initial raw material with methanol in the presence of solid acid; and
Lactam metalloprotease inhibitors
-
, (2008/06/13)
The present application describes novel lactams and derivatives thereof of formula I: or pharmaceutically acceptable salt forms thereof, wherein rings ring B is a 4-8 membered cyclic amide containing from 0-3 additional heteroatoms selected from N, O, and S, which are useful as metalloprotease inhibitors.
